Entia Biosciences, Inc. (ERGO)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 2, 2025
Entia Biosciences Revenue
In the year 2016, Entia Biosciences had annual revenue of $265.47K, down -23.48%. Entia Biosciences had revenue of $45.99K in the quarter ending December 31, 2016, a decrease of -32.77%.
Revenue
265.47K
Revenue Growth
-23.48%
P/S Ratio
0.01
Revenue / Employee
37.92K
Employees
7
Market Cap
3.41K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2016 | 265.47K | -81.44K | -23.48% |
Dec 31, 2015 | 346.91K | -309.43K | -47.14% |
Dec 31, 2014 | 656.34K | 341.60K | 108.53% |
Dec 31, 2013 | 314.75K | -54.53K | -14.77% |
Dec 31, 2012 | 369.27K | -34.07K | -8.45% |
Dec 31, 2011 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Jul 31, 2008 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |